Approval · Notice of Compliance 4531 · 1996
GEN-MEDROXY: Notice of Compliance 4531
Issued November 15, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4531
- Date
- November 15, 1996
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Progestagen-progestational steroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-MEDROXY | 02229838 | Cancelled Post Market |
| GEN-MEDROXY | 02229839 | Cancelled Post Market |
| GEN-MEDROXY | 02229840 | Cancelled Post Market |
Medicinal ingredients
- MEDROXYPROGESTERONE ACETATE 2.5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 5 MG per TAB
- MEDROXYPROGESTERONE ACETATE 10 MG per TAB